- Home
- FMBH vs INBX Comparison
FMBH vs INBX Comparison
Compare FMBH & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FMBH | INBX |
|---|---|---|
| Founded | 1865 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 951.4M | 1.1B |
| IPO Year | 1995 | 2024 |
Fundamental Metrics
Financial Performance| Metric | FMBH | INBX |
|---|---|---|
| Price | $39.29 | $68.70 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 5 | 2 |
| Target Price | ★ $43.40 | N/A |
| AVG Volume (30 Days) | 88.9K | ★ 133.7K |
| Earning Date | 04-30-2026 | 01-01-0001 |
| Dividend Yield | ★ 2.52% | N/A |
| EPS Growth | 16.06 | ★ 649.90 |
| EPS | ★ 3.83 | N/A |
| Revenue | N/A | ★ $200,000.00 |
| Revenue This Year | $9.38 | $563.00 |
| Revenue Next Year | $6.55 | N/A |
| P/E Ratio | $10.37 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $27.58 | $10.81 |
| 52 Week High | $44.85 | $94.57 |
Technical Indicators
Market Signals| Indicator | FMBH | INBX |
|---|---|---|
| Relative Strength Index (RSI) | 34.39 | 39.32 |
| Support Level | $34.53 | $28.54 |
| Resistance Level | $39.89 | $85.97 |
| Average True Range (ATR) | 1.22 | 4.31 |
| MACD | -0.31 | -0.73 |
| Stochastic Oscillator | 12.23 | 10.57 |
Price Performance
Historical ComparisonAbout FMBH First Mid Bancshares Inc.
First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.